Disease Control Data, nr-axSpA
Por um escritor misterioso
Descrição
Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.
Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients – baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice – topic of
Extra-articular manifestations and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis.
Radiographic axial versus nonradiographic axial spondyloarthritis: Comparison of the disease activity parameters and the disease activity and functional scores: RBSMR study
Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis.
Building a Treatment Plan for active Non-radiographic Axial Spondyloarthritis (nr-axSpA)
Axial spondyloarthritis: concept, construct, classification and implications for therapy
Targeting inflammatory pathways in axial spondyloarthritis, Arthritis Research & Therapy
Non-Radiographic Axial Spondyloarthritis: Symptoms of Inflammatory Back Pain
Study flow diagram. axSpA: axial spondyloarthritis; TNF-α: tumor
Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter
Understanding Axial Spondyloarthritis: A Primer for Managed Care
FDA Approval Of The First nr-AxSpA Biologics Projecting Regulatory Market Dynamics
